Sun M - Search Results

1

TOX deficiency facilitates the differentiation of IL-17A-producing γδ T cells to drive autoimmune hepatitis.

He Q, Lu Y, Tian W, Jiang R, Yu W, Liu Y, Sun M, Wang F, Zhang H, Wu N, Dong Z, Sun B. He Q, et al. Among authors: sun m, sun b. Cell Mol Immunol. 2022 Oct;19(10):1102-1116. doi: 10.1038/s41423-022-00912-y. Epub 2022 Aug 19. Cell Mol Immunol. 2022. PMID: 35986136 Free PMC article.

2

Synergetic regulation of kupffer cells, extracellular matrix and hepatic stellate cells with versatile CXCR4-inhibiting nanocomplex for magnified therapy in liver fibrosis.

Wu P, Luo X, Sun M, Sun B, Sun M. Wu P, et al. Among authors: sun m, sun b. Biomaterials. 2022 May;284:121492. doi: 10.1016/j.biomaterials.2022.121492. Epub 2022 Mar 29. Biomaterials. 2022. PMID: 35395456

3

Engineered EGCG-Containing Biomimetic Nanoassemblies as Effective Delivery Platform for Enhanced Cancer Therapy.

Wu P, Zhang H, Yin Y, Sun M, Mao S, Chen H, Deng Y, Chen S, Li S, Sun B. Wu P, et al. Among authors: sun m, sun b. Adv Sci (Weinh). 2022 May;9(15):e2105894. doi: 10.1002/advs.202105894. Epub 2022 Mar 25. Adv Sci (Weinh). 2022. PMID: 35486032 Free PMC article.

4

Manipulating Offense and Defense Signaling to Fight Cold Tumors with Carrier-Free Nanoassembly of Fluorinated Prodrug and siRNA.

Wu P, Zhang H, Sun M, Mao S, He Q, Shi Y, Deng Y, Dong Z, Xu Q, Zhao C, Zhang W, Sun B. Wu P, et al. Among authors: sun m, sun b. Adv Mater. 2022 Sep;34(38):e2203019. doi: 10.1002/adma.202203019. Epub 2022 Aug 21. Adv Mater. 2022. PMID: 35918816

5

A decision tree model to predict liver cirrhosis in hepatocellular carcinoma patients: a retrospective study.

Zhou Z, Chen C, Sun M, Xu X, Liu Y, Liu Q, Wang J, Yin Y, Sun B. Zhou Z, et al. Among authors: sun m, sun b. PeerJ. 2023 Aug 24;11:e15950. doi: 10.7717/peerj.15950. eCollection 2023. PeerJ. 2023. PMID: 37641600 Free PMC article.

6

A pan-cancer analysis of the prognostic and immunological roles of matrix metalloprotease-1 (MMP1) in human tumors.

Mao S, Xia A, Tao X, Ye D, Qu J, Sun M, Wei H, Li G. Mao S, et al. Among authors: sun m. Front Oncol. 2023 Jan 13;12:1089550. doi: 10.3389/fonc.2022.1089550. eCollection 2022. Front Oncol. 2023. PMID: 36727076 Free PMC article.

7

Co-delivery of EGCG and melittin with self-assembled fluoro-nanoparticles for enhanced cancer therapy.

Sun M, Wu Y, Zhou Z, Liu S, Mao S, Li G. Sun M, et al. Aging (Albany NY). 2023 Jun 5;15(11):4875-4888. doi: 10.18632/aging.204769. Epub 2023 Jun 5. Aging (Albany NY). 2023. PMID: 37277118 Free PMC article.

8

Conversion therapy for massive hepatocellular carcinoma: A case report and literature review.

Zhou Z, Xu X, Sun M, Liu Y, Liu Q, Chen C, Yin Y. Zhou Z, et al. Among authors: sun m. Clin Case Rep. 2023 Jun 13;11(6):e7533. doi: 10.1002/ccr3.7533. eCollection 2023 Jun. Clin Case Rep. 2023. PMID: 37323266 Free PMC article.

9

HMGCL-induced β-hydroxybutyrate production attenuates hepatocellular carcinoma via DPP4-mediated ferroptosis susceptibility.

Cui X, Yun X, Sun M, Li R, Lyu X, Lao Y, Qin X, Yu W. Cui X, et al. Among authors: sun m. Hepatol Int. 2023 Apr;17(2):377-392. doi: 10.1007/s12072-022-10459-9. Epub 2022 Dec 12. Hepatol Int. 2023. PMID: 36508088 Free PMC article.

10

Correction to: HMGCL‑induced β‑hydroxybutyrate production attenuates hepatocellular carcinoma via DPP4‑mediated ferroptosis susceptibility.

Cui X, Yun X, Sun M, Li R, Lyu X, Lao Y, Qin X, Yu W. Cui X, et al. Among authors: sun m. Hepatol Int. 2023 Apr;17(2):516. doi: 10.1007/s12072-022-10476-8. Epub 2023 Jan 13. Hepatol Int. 2023. PMID: 36635611 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16,263 results

Search Page

Filters